.png?width=11&height=11&name=plus-img%20(1).png){kind=small}
Jonathan Gardner reflects on the Firm’s appointment as co-lead counsel in a shareholder suit against Biogen Inc.
Labaton Sucharow was recently appointed co-lead counsel in a suit alleging that Biogen and its executives concealed the company’s true financial condition, leading to a stock drop when the company slashed its revenue growth forecasts for 2015.
Partner Jonathan Gardner told Law360 that the firm was happy with the order. "We’re pleased to have been appointed by the court and look forward to vigorously litigating the case on behalf of the class," he said.
New York